Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ALTO-103
- Development stage
- Unknown
- Lead developer
- Alto Neuroscience
- Modality
- Small Molecules
01
Overview
**ALTO-103** is an investigational proprietary fixed-dose combination of low-dose small molecules developed by Alto Neuroscience. It was designed using a synergistic-pharmacology approach to converge on the cyclic adenosine monophosphate signaling pathway, with the aim of improving cognitive, attentional, executive-function, motivational-salience, and alertness measures relevant to neuropsychiatric disorders. In a Phase 1 human brain-mechanism study, ALTO-103 showed significant pharmacodynamic effects versus placebo and was reported to be well tolerated; its individual active components and direct molecular targets have not been publicly disclosed. ([businesswire.com](https://www.businesswire.com/news/home/20221214005419/en/Alto-Neuroscience-Announces-Positive-Data-from-Phase-1-Study-Evaluating-Brain-Effects-of-Novel-Drug-Combinations))
- Other names
- ALTO103ALTO-103ALTO 103
Beyond the preview
Go deeper on ALTO-103.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ALTO-103.